Kbc Group Nv Jazz Pharmaceuticals PLC Transaction History

Kbc Group Nv

$32.2 Billion
Q1 2025

A detailed history of Kbc Group Nv transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Kbc Group Nv holds 243,938 shares of JAZZ stock, worth $26.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

243,938

Previous 236,318 3.22%

Holding current value

$26.1 Million

Previous $29.1 Million 4.06%

% of portfolio

0.09%

Previous 0.08%

46 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$120.07 - $144.17 $914,933 - $1.1 Million	7,620 Added 3.22%	243,938 $30.3 Million
Q4 2024 Jan 22, 2025	BUY	$107.32 - $127.74 $860,062 - $1.02 Million	8,014 Added 3.51%	236,318 $29.1 Million
Q3 2024 Nov 06, 2024	SELL	$100.57 - $116.37 $15 Million - $17.4 Million	-149,549 Reduced 39.58%	228,304 $25.4 Million
Q2 2024 Jul 17, 2024	BUY	$103.94 - $118.98 $8.29 Million - $9.49 Million	79,797 Added 26.77%	377,853 $40.3 Million
Q1 2024 May 08, 2024	BUY	$115.19 - $132.77 $15.5 Million - $17.8 Million	134,198 Added 81.9%	298,056 $35.9 Million
Q4 2023 Feb 13, 2024	BUY	$114.26 - $136.0 $17.9 Million - $21.3 Million	156,707 Added 2191.4%	163,858 $20.2 Million
Q3 2023 Feb 15, 2024	BUY	$122.0 - $145.31 $405,162 - $482,574	3,321 Added 46.44%	10,472 $1.36 Million
Q2 2023 Feb 15, 2024	SELL	$122.5 - $147.16 $12.7 Million - $15.2 Million	-103,391 Reduced 93.53%	7,151 $887,000
Q2 2023 Jul 28, 2023	SELL	$122.5 - $147.16 $3.04 Million - $3.66 Million	-24,849 Reduced 77.65%	7,151 $887,000
Q1 2023 Feb 14, 2024	SELL	$133.98 - $160.47 $7.37 Million - $8.83 Million	-54,995 Reduced 63.22%	32,000 $4.68 Million
Q1 2023 May 04, 2023	SELL	$133.98 - $160.47 $10.5 Million - $12.6 Million	-78,446 Reduced 71.03%	32,000 $4.68 Million
Q4 2022 Feb 14, 2024	SELL	$129.72 - $159.85 $4.65 Million - $5.73 Million	-35,847 Reduced 29.18%	86,995 $13.9 Million
Q3 2022 Feb 15, 2024	SELL	$126.59 - $161.18 $6.75 Million - $8.59 Million	-53,316 Reduced 32.54%	110,542 $14.7 Million
Q3 2022 Nov 08, 2022	SELL	$126.59 - $161.18 $1.55 Million - $1.98 Million	-12,261 Reduced 9.99%	110,446 $14.7 Million
Q2 2022 Feb 14, 2024	BUY	$141.59 - $168.66 $7.77 Million - $9.25 Million	54,861 Added 80.7%	122,842 $19.2 Million
Q2 2022 Jul 26, 2022	BUY	$141.59 - $168.66 $7.75 Million - $9.23 Million	54,726 Added 80.5%	122,707 $19.1 Million
Q1 2022 Feb 14, 2024	BUY	$129.64 - $160.7 $7.05 Million - $8.74 Million	54,408 Added 400.85%	67,981 $10.6 Million
Q1 2022 May 06, 2022	BUY	$129.64 - $160.7 $7.05 Million - $8.74 Million	54,408 Added 400.85%	67,981 $10.6 Million
Q4 2021 Feb 14, 2024	SELL	$119.87 - $145.67 $18 Million - $21.9 Million	-150,285 Reduced 91.72%	13,573 $1.73 Million
Q4 2021 Feb 03, 2022	SELL	$119.87 - $145.67 $14,144 - $17,189	-118 Reduced 0.86%	13,573 $1.73 Million
Q3 2021 Nov 10, 2021	SELL	$128.64 - $184.79 $16.4 Million - $23.6 Million	-127,481 Reduced 90.3%	13,691 $1.78 Million
Q2 2021 Aug 11, 2021	BUY	$160.2 - $186.42 $16.7 Million - $19.5 Million	104,555 Added 285.54%	141,172 $25.1 Million
Q1 2021 Apr 26, 2021	BUY	$150.19 - $173.5 $524,763 - $606,209	3,494 Added 10.55%	36,617 $6.02 Million
Q4 2020 Feb 10, 2021	BUY	$140.71 - $165.05 $3.22 Million - $3.78 Million	22,872 Added 223.12%	33,123 $5.47 Million
Q3 2020 Oct 28, 2020	SELL	$105.46 - $144.13 $250,889 - $342,885	-2,379 Reduced 18.84%	10,251 $1.46 Million
Q2 2020 Aug 10, 2020	SELL	$95.68 - $121.88 $3.9 Million - $4.97 Million	-40,763 Reduced 76.35%	12,630 $1.39 Million
Q1 2020 May 04, 2020	SELL	$87.74 - $152.74 $7.98 Million - $13.9 Million	-90,940 Reduced 63.01%	53,393 $5.33 Million
Q4 2019 Feb 11, 2020	BUY	$117.65 - $153.73 $4.14 Million - $5.42 Million	35,227 Added 32.29%	144,333 $21.5 Million
Q3 2019 Nov 07, 2019	BUY	$125.18 - $143.24 $13.6 Million - $15.5 Million	108,276 Added 13045.3%	109,106 $14 Million
Q2 2019 Dec 03, 2019	SELL	$125.55 - $144.48 $12.9 Million - $14.8 Million	-102,503 Reduced 99.2%	830 $118,000
Q2 2019 Jul 30, 2019	BUY	$125.55 - $144.48 $12.9 Million - $14.8 Million	102,503 Added 12349.76%	103,333 $0
Q1 2019 Dec 03, 2019	SELL	$121.81 - $142.95 $12.4 Million - $14.5 Million	-101,541 Reduced 99.19%	830 $119,000
Q1 2019 May 10, 2019	BUY	$121.81 - $142.95 $12.4 Million - $14.5 Million	101,541 Added 12233.86%	102,371 $0
Q4 2018 Dec 03, 2019	SELL	$115.94 - $166.74 $18.6 Million - $26.8 Million	-160,783 Reduced 99.49%	830 $103,000
Q4 2018 Jan 31, 2019	BUY	$115.94 - $166.74 $18.6 Million - $26.8 Million	160,783 Added 19371.45%	161,613 $20 Million
Q3 2018 Dec 03, 2019	SELL	$161.01 - $180.57 $21.5 Million - $24.1 Million	-133,676 Reduced 99.38%	830 $140,000
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $21.5 Million - $24.1 Million	133,676 Added 16105.54%	134,506 $0
Q2 2018 Dec 03, 2019	SELL	$146.33 - $183.18 $15.8 Million - $19.8 Million	-108,205 Reduced 99.24%	830 $143,000
Q2 2018 Aug 03, 2018	BUY	$146.33 - $183.18 $15.8 Million - $19.8 Million	108,205 Added 13036.75%	109,035 $0
Q1 2018 Dec 03, 2019	SELL	$135.59 - $157.16 $17.4 Million - $20.1 Million	-127,967 Reduced 99.36%	830 $125,000
Q1 2018 May 09, 2018	BUY	$135.59 - $157.16 $17.4 Million - $20.1 Million	127,967 Added 15417.71%	128,797 $0
Q4 2017 Dec 03, 2019	SELL	$131.06 - $150.39 $23.5 Million - $27 Million	-179,556 Reduced 99.54%	830 $112,000
Q4 2017 Feb 07, 2018	BUY	$131.06 - $150.39 $23.5 Million - $27 Million	179,556 Added 21633.25%	180,386 $0
Q3 2017 Dec 03, 2019	SELL	$142.62 - $155.6 $35.9 Million - $39.2 Million	-251,873 Reduced 99.67%	830 $121,000
Q3 2017 Nov 13, 2017	BUY	$142.62 - $155.6 $35.9 Million - $39.2 Million	251,873 Added 30346.14%	252,703 $0
Q2 2017 Dec 03, 2019	BUY	N/A	830	830 $129,000

Others Institutions Holding JAZZ

# of Institutions

600

Shares Held

60.5M

Call Options Held

424K

Put Options Held

190K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account